Cargando…

FOXC2 augments tumor propagation and metastasis in osteosarcoma

Osteosarcoma is a highly malignant tumor that contains a small subpopulation of tumor-propagating cells (also known as tumor-initiating cells) characterized by drug resistance and high metastatic potential. The molecular mechanism by which tumor-propagating cells promote tumor growth is poorly under...

Descripción completa

Detalles Bibliográficos
Autores principales: Gozo, Maricel C., Jia, Dongyu, Aspuria, Paul-Joseph, Cheon, Dong-Joo, Miura, Naoyuki, Walts, Ann E., Karlan, Beth Y., Orsulic, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356590/
https://www.ncbi.nlm.nih.gov/pubmed/27634875
http://dx.doi.org/10.18632/oncotarget.11990
_version_ 1782515868405596160
author Gozo, Maricel C.
Jia, Dongyu
Aspuria, Paul-Joseph
Cheon, Dong-Joo
Miura, Naoyuki
Walts, Ann E.
Karlan, Beth Y.
Orsulic, Sandra
author_facet Gozo, Maricel C.
Jia, Dongyu
Aspuria, Paul-Joseph
Cheon, Dong-Joo
Miura, Naoyuki
Walts, Ann E.
Karlan, Beth Y.
Orsulic, Sandra
author_sort Gozo, Maricel C.
collection PubMed
description Osteosarcoma is a highly malignant tumor that contains a small subpopulation of tumor-propagating cells (also known as tumor-initiating cells) characterized by drug resistance and high metastatic potential. The molecular mechanism by which tumor-propagating cells promote tumor growth is poorly understood. Here, we report that the transcription factor forkhead box C2 (FOXC2) is frequently expressed in human osteosarcomas and is important in maintaining osteosarcoma cells in a stem-like state. In osteosarcoma cell lines, we show that anoikis conditions stimulate FOXC2 expression. Downregulation of FOXC2 decreases anchorage-independent growth and invasion in vitro and lung metastasis in vivo, while overexpression of FOXC2 increases tumor propagation in vivo. In osteosarcoma cell lines, we demonstrate that high levels of FOXC2 are associated with and required for the expression of osteosarcoma tumor-propagating cell markers. In FOXC2 knockdown cell lines, we show that CXCR4, a downstream target of FOXC2, can restore osteosarcoma cell invasiveness and metastasis to the lung.
format Online
Article
Text
id pubmed-5356590
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53565902017-03-24 FOXC2 augments tumor propagation and metastasis in osteosarcoma Gozo, Maricel C. Jia, Dongyu Aspuria, Paul-Joseph Cheon, Dong-Joo Miura, Naoyuki Walts, Ann E. Karlan, Beth Y. Orsulic, Sandra Oncotarget Research Paper Osteosarcoma is a highly malignant tumor that contains a small subpopulation of tumor-propagating cells (also known as tumor-initiating cells) characterized by drug resistance and high metastatic potential. The molecular mechanism by which tumor-propagating cells promote tumor growth is poorly understood. Here, we report that the transcription factor forkhead box C2 (FOXC2) is frequently expressed in human osteosarcomas and is important in maintaining osteosarcoma cells in a stem-like state. In osteosarcoma cell lines, we show that anoikis conditions stimulate FOXC2 expression. Downregulation of FOXC2 decreases anchorage-independent growth and invasion in vitro and lung metastasis in vivo, while overexpression of FOXC2 increases tumor propagation in vivo. In osteosarcoma cell lines, we demonstrate that high levels of FOXC2 are associated with and required for the expression of osteosarcoma tumor-propagating cell markers. In FOXC2 knockdown cell lines, we show that CXCR4, a downstream target of FOXC2, can restore osteosarcoma cell invasiveness and metastasis to the lung. Impact Journals LLC 2016-09-13 /pmc/articles/PMC5356590/ /pubmed/27634875 http://dx.doi.org/10.18632/oncotarget.11990 Text en Copyright: © 2016 Gozo et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Gozo, Maricel C.
Jia, Dongyu
Aspuria, Paul-Joseph
Cheon, Dong-Joo
Miura, Naoyuki
Walts, Ann E.
Karlan, Beth Y.
Orsulic, Sandra
FOXC2 augments tumor propagation and metastasis in osteosarcoma
title FOXC2 augments tumor propagation and metastasis in osteosarcoma
title_full FOXC2 augments tumor propagation and metastasis in osteosarcoma
title_fullStr FOXC2 augments tumor propagation and metastasis in osteosarcoma
title_full_unstemmed FOXC2 augments tumor propagation and metastasis in osteosarcoma
title_short FOXC2 augments tumor propagation and metastasis in osteosarcoma
title_sort foxc2 augments tumor propagation and metastasis in osteosarcoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356590/
https://www.ncbi.nlm.nih.gov/pubmed/27634875
http://dx.doi.org/10.18632/oncotarget.11990
work_keys_str_mv AT gozomaricelc foxc2augmentstumorpropagationandmetastasisinosteosarcoma
AT jiadongyu foxc2augmentstumorpropagationandmetastasisinosteosarcoma
AT aspuriapauljoseph foxc2augmentstumorpropagationandmetastasisinosteosarcoma
AT cheondongjoo foxc2augmentstumorpropagationandmetastasisinosteosarcoma
AT miuranaoyuki foxc2augmentstumorpropagationandmetastasisinosteosarcoma
AT waltsanne foxc2augmentstumorpropagationandmetastasisinosteosarcoma
AT karlanbethy foxc2augmentstumorpropagationandmetastasisinosteosarcoma
AT orsulicsandra foxc2augmentstumorpropagationandmetastasisinosteosarcoma